Discover more on Sickle Cell Disease with VJHemOnc
Sickle cell disease (SCD) is one of the most common serious genetic diseases in childhood and is more common in those of African or Mediterranean ancestry. Hematopoietic stem cell transplant may cure the condition, but is not suitable for most patients with SCD. So for the majority of patients, SCD is a life-long condition, and they require treatments such as blood transfusions and hydroxyurea, as well as symptom control with opioids.
Learn more on VJHemOnc about newer treatments, as well as exciting developments in gene therapy for SCD.
